华北制药：2025年半年度归属于上市公司股东的净利润同比增长71.56%

Core Insights - North China Pharmaceutical announced its financial results for the first half of 2025, reporting a revenue of 5,275,037,790.20 yuan, which represents a year-on-year growth of 0.84% [2] - The net profit attributable to shareholders of the listed company was 123,497,402.89 yuan, showing a significant year-on-year increase of 71.56% [2] Financial Performance - Revenue for the first half of 2025 reached 5.28 billion yuan, reflecting a slight increase compared to the previous year [2] - The net profit for the same period was approximately 123.50 million yuan, indicating a strong growth trajectory in profitability [2]